With support from funding agencies as well as privately funded initiatives our group is growing. We are expanding our research efforts and are looking for committed team players interested in making a difference in health research and the lives of individuals living with neurodegenerative disorders including MS.
• A recent CIHR project grant to study a preclinical model of primary progressive MS based on a variant identified in families impacted with a particularly severe and aggressive form of MS
• The mutation impacts Nr1h3 or LXRA such that immunomodulatory pathways are disrupted as is cholesterol reverse transport/lipid metabolism.
Are you interested? Click on the button below for all the information you need and to apply.